Search Results 11-20 of 18802 for intestinal metaplasia

  1. Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus with Radiofrequency Ablation - Mayo Clinic

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  2. Barrett's Esophagus Clinical Trials - Mayo Clinic Research

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  3. A Study to Evaluate Bile Acid Reflux in Patients with Recurrent Barrett’s Esophagus - Mayo Clinic

    ... intestinal metaplasia, dysplasia, or EAC versus patients who achieved complete remission for at least > 1 year following initial endoscopic intervention ...

  4. Mayo Clinic Q and A: Determining foods to avoid when managing Barrett's esophagus

    That means the normal cells of the esophagus, called “squamous cells,” are replaced by intestinal cells. “Metaplasia” means the replacement of one cell by ...

  5. Assessing the timeline, location and patterns of recurrence in patients achieving complete remission after radiofrequency ablation - Mayo Clinic

    Treatment with RFA and resection can reduce the risk of cancer progression and induce complete remission of intestinal metaplasia (CRIM), both endoscopically ...

  6. Barrett's esophagus - Symptoms and causes - Mayo Clinic

    Frequent heartburn and regurgitation of stomach contents; Difficulty swallowing food; Less commonly, chest pain. Curiously, approximately half of the people ...

  7. Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus - Mayo Clinic

    ... intestinal metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or <50% eradication of Barrett's ...

  8. Assessing the prevalence of Barrett's esophagus in patients with scleroderma - Mayo Clinic

    ... intestinal metaplasia. BE , which can progress to dysplasia, is a known risk factor for esophageal adenocarcinoma. A handful of older, smaller studies ...

  9. Publications - Dora M. Lam-Himlin, M.D. - Mayo Clinic

    Intestinal metaplasia of the gastric cardia: findings in patients with versus without Barrett's esophagus. Gastrointest Endosc. 2019 Apr; 89 (4):759-768 ...

  10. Bone metastasis - Doctors and departments - Mayo Clinic

    Intestinal Metaplasia: What do you do to lower the risk of cancer? 106 Replies Mon, Sep 22, 2025. rita8898 · Anyone have cancer with unknown primary? 211 ...